Moderna Free Cash Flow (Quarterly) Analysis

Moderna Inc (MRNA)

39.77 -2.37 (-5.62%) USD | NASDAQ | Nov 14, 16:00

39.00 -0.77 (-1.94%) After-Hours: 07:52

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2024	-1.717B
June 30, 2024	-1.456B
March 31, 2024	-1.185B
December 31, 2023	402.00M
September 30, 2023	-1.74B
June 30, 2023	-1.149B
March 31, 2023	-1.338B
December 31, 2022	1.57B
September 30, 2022	163.00M
June 30, 2022	217.00M
March 31, 2022	2.631B
December 31, 2021	3.19B
September 30, 2021	3.177B
June 30, 2021	4.033B

Date	Value
March 31, 2021	2.936B
December 31, 2020	1.24B
September 30, 2020	874.00M
June 30, 2020	-43.00M
March 31, 2020	-112.00M
December 31, 2019	-106.16M
September 30, 2019	-113.80M
June 30, 2019	-119.17M
March 31, 2019	-151.86M
December 31, 2018	-104.66M
September 30, 2018	-106.35M
June 30, 2018	-82.33M
March 31, 2018	-143.29M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-1.74B

Minimum

Sep 2023

4.033B

Maximum

Jun 2021

579.34M

Average

190.00M

Median

Free Cash Flow (Quarterly) Benchmarks